Galia Rahav, MD

Head of Infectious Disease Unit
Sheba Medical Center and Tel Aviv University

Disclosure: AstraZeneca (Individual(s) Involved: Self): Scientific Research Study Investigator

Presentation(s):

• 147 - Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial

  Oral Abstract